Parallel Advisors, LLC Hutchmed (China) LTD Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$15.52 - $35.65 $3,305 - $7,593	-213 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$28.89 - $35.33 $1,993 - $2,437	69 Added 47.92%	213 $7,000
Q1 2021 Apr 23, 2021	BUY	$27.01 - $36.8 $999 - $1,361	37 Added 34.58%	144 $4,000
Q2 2020 Jul 16, 2020	BUY	$17.65 - $28.05 $511 - $813	29 Added 37.18%	107 $2,000
Q1 2020 Apr 27, 2020	SELL	$15.19 - $29.51 $25,291 - $49,134	-1,665 Reduced 95.52%	78 $1,000
Q4 2019 Jan 30, 2020	BUY	$17.17 - $25.95 $18,114 - $27,377	1,055 Added 153.34%	1,743 $44,000
Q3 2019 Nov 01, 2019	BUY	$17.84 - $22.69 $12,273 - $15,610	688 New	688 $12,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.47B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.